Sareum Holdings (LSE:SAR) Additional Paid-In Capital : £22.68 Mil(As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Sareum Holdings Additional Paid-In Capital?

Sareum Holdings's quarterly additional paid-in capital stayed the same from Dec. 2022 (£20.93 Mil) to Jun. 2023 (£20.93 Mil) but then increased from Jun. 2023 (£20.93 Mil) to Dec. 2023 (£22.68 Mil).

Sareum Holdings's annual additional paid-in capital increased from Jun. 2021 (£17.24 Mil) to Jun. 2022 (£20.93 Mil) but then stayed the same from Jun. 2022 (£20.93 Mil) to Jun. 2023 (£20.93 Mil).

Sareum Holdings Additional Paid-In Capital Historical Data

The historical data trend for Sareum Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sareum Holdings Additional Paid-In Capital Chart

Sareum Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

Get a 7-Day Free Trial

13.16

14.77

17.24

20.93

Sareum Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															20.96	20.93	20.93	20.93	22.68

Sareum Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sareum Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sareum Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sareum Holdings (LSE:SAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (LSE:SAR) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RYH0:Germany

Address

Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX

Website

http://www.sareum.com

Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.